|
MDA-MB-231
|
G0/G1 (%)
|
S (%)
|
G2/M (%)
|
|---|
|
Control
|
52.70 ± 0.52
|
43.35 ± 0.95
|
4.05 ± 0.43
|
|
DMSO
|
55.23 ± 1.17
|
39.69 ± 2.04
|
5.09 ± 2.31
|
|
TSA
|
59.25 ± 0.64
|
35.45 ± 0.38
|
5.30 ± 0.34*
|
|
DAC
|
46.91 ± 0.16
|
43.11 ± 0.19
|
9.98 ± 0.29***
|
|
DAC+TSA
|
46.42 ± 0.81
|
27.30 ± 1.59
|
25.29 ± 2.65**
|
|
Paclitaxel
|
42.85 ± 6.51
|
45.13 ± 5.21
|
12.01 ± 3.43*
|
|
DAC+TSA+Paclitaxel
|
39.67 ± 2.12
|
14.6 8 ± 1.87
|
45.99 ± 0.32***
|
- *P < 0.05, **P < 0.01, ***P < 0.001 compared to control. The data were obtained from three independent experiments and are presented as the mean ± SD.
